6 million donkeys slaughtered for Chinese health supplement, charity says
Criminal networks have moved in since the African Union issued a moratorium on donkey slaughter in 2024. PHOTO: AFP
ADDIS ABABA, Ethiopia – Almost six million donkeys are slaughtered annually for Chinese medicine, with severe knock-on effects for African villagers who rely on the animals, a Britain-based charity said on June 26.
It is driven by an increase in China's production of ejiao – a product marketed as a health supplement that uses collagen from donkey skins – which is a US$6.8 billion (S$8.6 billion) industry, according to China-based research firm Qianzhan.
China, whose donkey population has plummeted from 11 million in 1992 to 1.5 million in 2023, has turned to Africa to meet its demand.
With donkey populations falling, the African Union issued a 15-year moratorium on donkey slaughter in 2024.
Britain-based charity The Donkey Sanctuary said 'the ejiao industry drives a massive global trade in donkey skins, much of it illegal'.
It said around 5.9 million donkeys were killed worldwide in 2024.
The ejiao trade is expected to require at least 6.8 million donkey skins by 2027.
The rising value of donkeys means they have increasingly become targets for criminals.
'Traders exploit vulnerable people using large and sophisticated networks of agents to pressure donkey owners into selling their animals,' the charity said.
'Illegal networks operate across the continent, often without consequence, stealing and slaughtering donkeys in the night,' it added.
'Donkeys die in often unregulated, inhumane and unsanitary conditions, and large numbers perish on their way to slaughterhouses,' it said.
The impact on humans is particularly felt by women and children, who rely on donkeys for farming activities such as ploughing and for carrying goods to market.
The criminal operations also generated health risks, The Donkey Sanctuary said.
'The transportation of untreated skins and improper disposal of donkey carcasses risk triggering the spread of infectious diseases and damaging local ecosystems.' AFP
Join ST's Telegram channel and get the latest breaking news delivered to you.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
6 hours ago
- Straits Times
China confronts senior cancer surge with early detection, TCM
Early detection remains the most powerful tool in fighting cancer, experts say. PHOTO: AFP BEIJING - With a rapidly aging population, China is facing a pressing new public health challenge: cancer among the elderly. According to the latest data, people over the age of 60 now account for 60.7 per cent of all new cancer diagnoses in the country, making senior cancer care one of the most urgent priorities in China's efforts to deliver health for all. To promote cancer awareness among the elderly, China has launched a week-long national campaign. Medical experts are urging earlier detection, evidence-based treatment, and greater public education to counter myths that often cause seniors to delay or avoid care. China's demographic shift is accelerating: those aged 60 and above now make up more than 20 per cent of the population. By 2035, that figure is expected to reach 30 per cent, with the elderly population surpassing 400 million. A report by the Chinese Anti-Cancer Association shows that lung and gastrointestinal cancers are the most prevalent among older adults, accounting for roughly 65 per cent of malignant tumors in this age group. Other commonly diagnosed cancers include liver, lymphoma, prostate, and various blood cancers. 'Cancer among seniors is not uncommon, and it's closely tied to the accumulation of genetic mutations over time,' said Dr Xue Dong, a specialist in senior oncology at Peking University Cancer Hospital. Dr Xue explained that aging cells, a declining immune system, and long-term exposure to carcinogens significantly increase vulnerability. Early detection remains the most powerful tool in fighting cancer, experts say. In response, China's National Health Commission has called for enhanced public health services, including nationwide health checkups for adults aged 65 and older, with more frequent screenings for high-risk groups. Local initiatives are also underway. In Yancheng, East China's Jiangsu province, residents aged 60 to 69 now receive free testing for 12 common tumor markers. In Daqing, the northeastern province of Heilongjiang, authorities offer free screening for five major cancers - lung, breast, liver, upper gastrointestinal, and colorectal - to citizens aged between 45 and 74. Beyond cancer screenings, physicians also promote healthier daily routines. Dr Zhang Tong, a cancer specialist at Xiyuan Hospital of the China Academy of Chinese Medical Sciences, encourages seniors to maintain a balanced diet and practice traditional Chinese fitness exercises, such as Tai Chi and Baduanjin, which are known to enhance energy and immune function. Doctors also emphasise that traditional Chinese medicine can play a supportive role in conjunction with Western medical treatments. During chemotherapy, therapies like acupuncture and acupoint patches help relieve side effects such as nausea, appetite loss, and constipation. For radiation-related symptoms like skin damage and mouth ulcers, herbal baths and steam therapy offer relief. Dr Li Yuanqing, a colleague of Dr Xue at the same hospital, noted that clinical experience shows these approaches can ease patient discomfort during chemotherapy and radiotherapy. Additionally, experts warn of deep-rooted misperceptions. Many older patients place faith in miracle cures or folk remedies, while others fear that conventional treatments like surgery or chemotherapy will only accelerate their decline. 'Treating elderly cancer patients requires balance,' said Dr Xue. 'We can't simply apply treatments designed for younger people, nor should we dismiss care due to age. The key lies in personalised treatment, guided by both medical need and the patient's physical and emotional readiness.' 'With science and compassion as our prescription, more elderly cancer patients can look forward to a dignified late life,' Dr Xue said. CHINA DAILY/ASIA NEWS NETWORK Join ST's Telegram channel and get the latest breaking news delivered to you.
Straits Times
a day ago
- Straits Times
France bans smoking in beaches, in parks and bus shelters from June 29
Some 75,000 people are estimated to die from tobacco-related complications each year in France. PHOTO: REUTERS France bans smoking in beaches, in parks and bus shelters from June 29 PARIS - France will ban smoking on beaches and in parks, public gardens and bus shelters from June 29, the government said. The decree, published in the official government gazette on June 28, will also ban smoking outside libraries, swimming pools and schools, and is aimed at protecting children from passive smoking. The decree did not mention electronic cigarettes. Violaters of the ban will face a fine of €135. 'Tobacco must disappear from places where there are children,' Health and Family Minister Catherine Vautrin had said in May, underscoring 'the right of children to breathe pure air'. Cafe terraces are excluded from the ban. Some 75,000 people are estimated to die from tobacco-related complications each year in France. According to a recent opinion survey, six out of 10 French people (62 per cent) favour a smoking ban in public places. AFP Join ST's Telegram channel and get the latest breaking news delivered to you.
AsiaOne
a day ago
- AsiaOne
Eye care giant Alcon keeps 'lens' on the future with expanded manufacturing and logistics facility in Tuas, Singapore News
Eye care-device giant Alcon officially opened its expanded state-of-the art manufacturing and logistics facility in Tuas Biomedical Park on Friday (June 27) morning. This brings Alcon's investments in Singapore to more than US$600 million (S$765 million) since it began operations in Singapore back in 2005. The completed Tuas facility is one of the Swiss-American firm's largest high-tech manufacturing sites with Industry 4.0 capabilities, advanced automation and smart manufacturing systems to meet the increasing global demand for its contact lenses. Amid a growing middle class and rising demand for quality healthcare, the Asia-Pacific region continues to be the fastest-growing market for medical technology, with its market value projected to reach nearly S$300 billion by 2030. This puts the region second only to the US as a source of demand for medical technology (Medtech). "Singapore is home to some of the world's best-in-class Medtech manufacturing palnts. The sector has been growing steadily, with a manufacturing output of S$19.4 billion in 2023. This marks a $5.2 billion increase over the past decade," said Senior Minister of State for Trade and Industry Low Yen Ling at the opening ceremony of Alcon's expanded facility. Beyond strengthening innovation and supply chain resilience within Singapore's MedTech ecosystem, Alcon's investment is also expected to benefit Singaporean workers and small- and medium-sized enterprises (SMEs) in Singapore. Muhammad Haiqal Bin Sapuan, an associate supervisor at Alcon made the switch from the oil and gas industry, through the Career Conversion Programme (CCP), in 2022 to have more time with his family. A year and a half into his role as a senior technician, he was nominated by his peers to step up as an associate supervisor. [[nid:707984]] "That recognition gave me confidence. I started off as an interim, and it was tough at first, but the team's support made the difference," said Haiqal. To date, nearly 180 Singaporean workers have benefitted from the CCP to become Alcon associates. Alcon's new facility is expected to create new job opportunities in production operations, quality control and supply chain management. It is also expected to strengthen innovation and supply chain resilience within Singapore's Medtech ecosystem through initiatives such as the Partnership for Capability Transformation, which partners local SMEs to buiild capabilities from precision moulding to packaging, helping them to scale and compete globally. [[nid:715407]] editor@
